These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance? Restrepo RD Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384 [TBL] [Abstract][Full Text] [Related]
28. Mucus hypersecretion in respiratory disease. Chair's introduction. Basbaum C Novartis Found Symp; 2002; 248():1-2. PubMed ID: 12568484 [No Abstract] [Full Text] [Related]
29. CLCA1 and TMEM16A: the link towards a potential cure for airway diseases. Brett TJ Expert Rev Respir Med; 2015 Oct; 9(5):503-6. PubMed ID: 26296094 [TBL] [Abstract][Full Text] [Related]
30. Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFκB. Xie T; Luo G; Zhang Y; Wang X; Wang X; Wu M; Li G Clin Exp Allergy; 2015 Dec; 45(12):1812-22. PubMed ID: 26245530 [TBL] [Abstract][Full Text] [Related]
31. Regulation of airway surface liquid volume and mucus transport by active ion transport. Tarran R Proc Am Thorac Soc; 2004; 1(1):42-6. PubMed ID: 16113411 [TBL] [Abstract][Full Text] [Related]
32. [BCL1 POLYMORPHISM OF GLUCOCORTICOID RECEPTOR GENE AND RESPIRATORY DISEASES]. Prystupa LN; Garbuzova VY; Kmyta VV Lik Sprava; 2015; (1-2):43-8. PubMed ID: 26118026 [TBL] [Abstract][Full Text] [Related]
33. The pathophysiological role of mucus production in inflammatory airway diseases. Lundgren JD; Vestbo J Respir Med; 1995 May; 89(5):315-6. PubMed ID: 7638364 [No Abstract] [Full Text] [Related]
34. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy. Rogers DF Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087 [TBL] [Abstract][Full Text] [Related]
35. Mucous hypersecretion and relationship to cough. Nadel JA Pulm Pharmacol Ther; 2013 Oct; 26(5):510-3. PubMed ID: 23434445 [TBL] [Abstract][Full Text] [Related]